Benzydamine and Cetilpiridinium Lozenges4 de January de 2023
Hyoscine + Paracetamol film coated tablets16 de August de 2023
Table of contents
2022 KEY ACHIEVEMENTS
ELEVATE WITH OUR PRODUCTS
NEW DEVELOPMENTS IN OUR PIPELINE
Written by Veronica Madrid
Another year has passed, even more challenging than the previous one, where the Cough & Cold demand of products has significantly increased in an unpredictable economic context that caused unforeseeable pressures on supply chains, impacting our daily costs and regular processes.
More than ever, flexibility has been our key pillar, as day by day we had to redefine our plans and strategy according to our client’s needs in a complex and constantly changing environment.
I would like to take a moment to recognize our team and shareholders for all the accomplishments made during the year, which couldn’t be possible without their commitment, dedication and efforts.
This year we have made significant progress in growing our pipeline with 5 new developments and we are extremely excited to continue our research and innovation to develop future products within 2023.
This year we have also expanded our activity to new territories where Geiser Pharma was not present yet, such as Colombia, China and Vietnam and we have reinforced our expansion plans to Canada and Brazil for 2023.
This could not have been possible without the collaboration and trust of our clients and partners, that has also enabled us to sign 35 new contracts.
On behalf of Geiser’s team and Board of Directors, I sincerely thank you for your continued support despite all the difficulties and I am confident that we will be able to reach our goals and even exceed our challenging expectations for the upcoming exciting years.
2022 Key achievements
Elevate with our products
The treatment of occasional insomnia is another of our priorities. This is shown through our two doxylamine’s products, an effective API in reducing the time to sleep onset as well as to increase the depth and duration.
Doxylamine succinate is available in tablets, for the more traditional consumers, as well as in oral powder with strawberry flavour, an easy-to-use pharmaceutical form that does not require water that could differentiate yourself from competitors.
Hioscine & Paracetamol
Our extensive experience in the development of pharmaceutical products leads us to cover new therapeutic areas such as women’s health and pain relief. antispasmodic-analgesic coated tablets help to relieve from the pain of stronger abdominal cramps including menstrual cramps and urinary tract spasm.
The 10 mg of Hyoscine-N-butylbromide, an antispasmodic substance that relieves the pain by acting on the muscle, together with analgesic properties of the 500 mg of Paracetamol, allows cramped muscles to relax and simultaneously delivers fast relief from pain.
A product manufactured by a CMO with extensive experience with paracetamol that will be ready to be presented in agencies from the end of 2023.
New products in our pipeline
Short-term symptomatic relief of the sore throat in adults and children over the age of 12 years.
AMYL + CDBA SPRAY
Symptomatic relief of mouth and throat infections.
Propolis, Manuka Honey, Vit C, Matricaria, Erysim
Soothe and relieve sore throats.
Ibuprofen Soft Gel capsules
Relieve pain and reduce swelling
Lidocaine Combination Spray
Symptomatic relief of throat infections, including severe sore throats